203
Participants
Start Date
May 31, 2012
Primary Completion Date
February 28, 2016
Study Completion Date
December 31, 2016
nab-paclitaxel
nab-paclitaxel by IV infusion every 3 weeks until progression or toxicity
LKH Feldkirch, Feldkirch
Medical University Graz, Graz
Medical University Innsbruck, Innsbruck
LKH Leoben, Leoben
KH Barmherzige Schwestern Linz, Linz
LKH Salzburg, Salzburg
LKH St. Pölten, Sankt Pölten
LKH Steyr, Steyr
Medical University Vienna, Vienna
KH SMZ Ost, Vienna
LKH Vöcklabruck, Vöcklabruck
Klinikum Wels, Wels
LKH Wr. Neustadt, Wiener Neustadt
Lead Sponsor
Celgene
INDUSTRY